New Enterprise Associates

New Enterprise Associates is a venture capital firm founded in 1977 and based in Menlo Park, California, with offices in the United States, India and China. It makes investments across technology and healthcare startups at multiple stages, from seed to growth, including software, cloud, data, internet services, fintech, AI, e-commerce, and enterprise technology, as well as healthcare information technology, life sciences, medical devices, and biopharma. It also considers energy technology and infrastructure opportunities, such as solar, batteries and smart grids. The firm pursues a global approach, with activity in the United States, Asia and other regions, and supports companies through rounds of financing ranging from small to sizable investments as they scale. NEA focuses on building portfolios in software, IT services, consumer technology, and healthcare technology, backing ambitious entrepreneurs across sectors and geographies.

Michael Albert

Associate

Kate Barrett

Partner, Communications

Forest Baskett

General Partner

Ann Bordetsky

Partner

James Buxton MD

Principal

Past deals in Southern US

Second Front Systems

Series C in 2024
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.

Zenas BioPharma

Series C in 2024
Zenas BioPharma is a clinical-stage biopharmaceutical company focused on developing immune-based therapies for autoimmune and immune-mediated diseases. Based in Florida, United States, the company advances biologic programs and aims to modulate B cell–driven pathology. Its lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcγRIIb on B cells, thereby inhibiting harmful immune activity without depleting B cells.

Second Front Systems

Venture Round in 2024
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.

Second Front Systems

Series B in 2023
Second Front Systems develops software that facilitates government access to innovative commercial technologies for national security missions. Its flagship product, Atlas Fulcrum, enables identification, assessment, and secure deployment of these technologies. The company also offers program management services and High Technology Council, an enterprise consortium fostering collaboration between market players.

ZeroFOX

Post in 2022
ZeroFOX is a cybersecurity company that provides external threat intelligence and protection against social media–based threats. It operates a cloud-based platform delivering real-time social threat analytics, protection, and monitoring to safeguard brands, people, and data across the public attack surface. Its solutions address phishing, credential compromise, impersonation, information leakage, brand hijacking, and physical or reputational risks to executives and high-profile individuals, with services including managed monitoring and protection. The company supports industries such as financial services, retail, government, healthcare, technology, education, media, and sports, and offers specialized protections for elections and high-value personnel.

QuoteWell

Series A in 2022
Founded in 2021, QuoteWell is a digital platform designed for the insurance industry. Based in Austin, Texas, it offers an integrated submission process that securely transmits insured applications to underwriters and enables agents and brokers to access modern risk transfer infrastructure.

UNION

Series B in 2021
UNION POS specializes in developing UNION TAB, a customizable iPad-based point of sale software tailored for bars and restaurants. Established in 2009 and headquartered in Austin, Texas, UNION POS focuses on meeting the unique needs of high-volume, high-touch venues. Their system offers a fast and intuitive interface that simplifies reporting and operational processes, allowing users to dedicate more time to customer engagement. The software includes features such as inventory management and loyalty programs, all supported by 24/7 live assistance and competitive processing fees. UNION POS aims to create a seamless experience that enhances operational efficiency while enabling businesses to concentrate on delivering exceptional service.

Slope.io

Series A in 2021
Slope.io, Inc. is a company that specializes in clinical trial logistics, catering to sponsors, contract research organizations (CROs), and research sites throughout the United States. Founded in 2016 and based in Mobile, Alabama, Slope.io offers a platform that streamlines the operational complexities associated with clinical trials. Its Slope.io Coordination service converts logistics requirements into organized schedules and workflows, while the Slope.io Kitting service provides customizable supply kits tailored to specific sites, patients, or study time points. The company emphasizes real-time coordination and complete traceability of devices, drugs, and kits from suppliers to research sites and patients.

IonQ

Post in 2021
IonQ is a quantum computing company that develops general-purpose quantum information processors based on trapped-ion technology. Its approach enables qubit replication, optical networkability, and optimized algorithms to support scalable quantum computation beyond classical capabilities. Founded in 2015 and based in College Park, Maryland, IonQ offers access to its quantum computers through cloud platforms, providing quantum-computing-as-a-service to a broad user base and select customers through its own cloud service. Revenue streams include QCaaS arrangements and related consulting and co-development contracts for algorithm design and system integration.

Airspan Networks

Post in 2021
Airspan Networks is a global provider of 4G broadband wireless systems and solutions. Established in 1992, the company delivers high-speed data, voice, and multimedia services to operators and vertical markets worldwide, serving over 500 operators across licensed and unlicensed frequency bands up to 6GHz. Its comprehensive product range includes indoor/outdoor small cells, open RAN base stations, fixed wireless access solutions, and related design services.

AllyAlign Health

Venture Round in 2021
AllyAlign Health, Inc. is a care management company that specializes in supporting patients with chronic and complex medical conditions. Founded in 2013 and headquartered in Glen Allen, Virginia, the company operates an advanced care management platform that facilitates real-time, collaborative care across various healthcare settings. This platform connects patients with care teams and integrates essential health information, care plans, and benefits details, empowering users to make informed care decisions. It offers mobile and web-based access, allowing patients and their families to view, share, create, and update information conveniently from home or from afar. The company's central database is HIPAA compliant and consolidates data from diverse sources, including electronic health records, lab tests, and clinical systems, ensuring comprehensive and meaningful clinical insights through semantic data modeling.

ThreatQuotient

Debt Financing in 2021
Founded in 2013, ThreatQuotient develops a threat intelligence platform that centralizes management of external sources with internal security solutions. Its platform integrates with various tools for contextual intelligence and automates processes to improve efficiency and effectiveness of security operations.

ThreatQuotient

Venture Round in 2021
Founded in 2013, ThreatQuotient develops a threat intelligence platform that centralizes management of external sources with internal security solutions. Its platform integrates with various tools for contextual intelligence and automates processes to improve efficiency and effectiveness of security operations.

Burrow

Series C in 2021
Burrow, Inc. is a New York-based company that designs, manufactures, and supplies luxury furniture for residential use. Founded in 2016, Burrow specializes in creating easy-to-move and customizable seating options such as sofas, sectionals, loveseats, and armchairs, as well as tables, rugs, and various accessories. The furniture is crafted from sustainably-sourced hardwood and features non-toxic, scratch- and stain-resistant fabrics. Burrow aims to provide customers with comfortable and stylish furnishing alternatives while avoiding traditional retail markups. The company operates showrooms in several states, including Washington, Massachusetts, Texas, and California, and also sells its products online. Additionally, Burrow has a manufacturing facility located in Mexico City, Mexico.

WireWheel

Series B in 2021
WireWheel, Inc. is a software company specializing in data privacy management solutions, designed to assist organizations in complying with various data protection regulations such as the EU GDPR and HIPAA. Established in 2016 and headquartered in Arlington, Virginia, WireWheel offers a cloud-based platform that integrates machine learning and data science to streamline privacy program management and subject rights request handling. The platform facilitates the automatic mapping of public cloud assets and aids in managing third-party relationships, enabling organizations to effectively navigate compliance obligations while maximizing the value of their data assets. WireWheel's innovative approach positions its clients to operationalize privacy effectively within their enterprises.

Personal Genome Diagnostics

Series C in 2021
Personal Genome Diagnostics, Inc. is a biotechnology company focused on patient-specific analyses of cancer genomes. Established in 2010 and headquartered in Baltimore, Maryland, the company has pioneered technologies for non-invasive "liquid biopsy" approaches, allowing for the detection of tumor-specific alterations in circulating cell-free DNA. Its offerings include the METDetect Assay for identifying MET gene amplifications, LungSelect for detecting actionable genetic alterations in non-small cell lung cancer patients, and PGDx elio plasma resolve, which analyzes various genetic mutations from plasma samples. Additionally, Personal Genome Diagnostics provides RNAcomplete, enabling researchers to extract both RNA and genomic DNA from a single tissue sample, and CancerXOME, which captures and analyzes coding regions of genes. The company collaborates with institutions like Mayo Clinic and partners with KingMed Diagnostics to enhance its research and diagnostic capabilities, thereby empowering oncologists and researchers with crucial genomic insights to combat cancer.

Bestow

Series C in 2020
Bestow Inc., established in 2016 and based in Dallas, Texas, operates as a digital life insurance company. It provides life insurance services to individuals, leveraging data-driven technology applications and algorithmic underwriting to assess risks efficiently. The company partners with top carriers to enhance processes from origination to administration, aiming to increase financial stability for all.

Everactive

Series C in 2020
Everactive develops ultra-low-power chips for battery-less wireless sensors, enabling end-to-end IoT data services. Its solutions provide low-cost, long-lived, intelligent instrumentation for industrial operations across various applications.

Bestow

Series B in 2020
Bestow Inc., established in 2016 and based in Dallas, Texas, operates as a digital life insurance company. It provides life insurance services to individuals, leveraging data-driven technology applications and algorithmic underwriting to assess risks efficiently. The company partners with top carriers to enhance processes from origination to administration, aiming to increase financial stability for all.

ZeroFOX

Series D in 2020
ZeroFOX is a cybersecurity company that provides external threat intelligence and protection against social media–based threats. It operates a cloud-based platform delivering real-time social threat analytics, protection, and monitoring to safeguard brands, people, and data across the public attack surface. Its solutions address phishing, credential compromise, impersonation, information leakage, brand hijacking, and physical or reputational risks to executives and high-profile individuals, with services including managed monitoring and protection. The company supports industries such as financial services, retail, government, healthcare, technology, education, media, and sports, and offers specialized protections for elections and high-value personnel.

NextNav

Series E in 2020
NextNav designs, develops, and deploys urban and indoor positioning technology solutions in the United States. Its positioning system allows mobile devices to determine their location in indoor and urban environments where GPS signals cannot be received, and provides location and height information with floor-level precision. The system is embedded into GPS chipsets, mobile phones, and other wireless devices. NextNav offers positioning services for E911, public safety, and emergency response, as well as consumer and commercial applications that require indoor location accuracy. It also provides Pinnacle, a Unity plug‑in that delivers precise altitude data to unlock 3D experiences for geolocation applications. Founded in 2007 and formerly known as Commlabs, the company is headquartered in Tyson's Corner, Virginia, with additional offices in Sunnyvale, California, and Bengaluru, India.

Upskill

Venture Round in 2019
Upskill designs and develops augmented reality software for industrial workforces. Its flagship platform, Skylight, enables companies to create smart glasses applications for various business scenarios, transforming operations using wearable devices. Serving industries such as manufacturing, healthcare, retail, and logistics, Upskill improves productivity, reduces errors, and enhances training.

IonQ

Series B in 2019
IonQ is a quantum computing company that develops general-purpose quantum information processors based on trapped-ion technology. Its approach enables qubit replication, optical networkability, and optimized algorithms to support scalable quantum computation beyond classical capabilities. Founded in 2015 and based in College Park, Maryland, IonQ offers access to its quantum computers through cloud platforms, providing quantum-computing-as-a-service to a broad user base and select customers through its own cloud service. Revenue streams include QCaaS arrangements and related consulting and co-development contracts for algorithm design and system integration.

Burrow

Series B in 2019
Burrow, Inc. is a New York-based company that designs, manufactures, and supplies luxury furniture for residential use. Founded in 2016, Burrow specializes in creating easy-to-move and customizable seating options such as sofas, sectionals, loveseats, and armchairs, as well as tables, rugs, and various accessories. The furniture is crafted from sustainably-sourced hardwood and features non-toxic, scratch- and stain-resistant fabrics. Burrow aims to provide customers with comfortable and stylish furnishing alternatives while avoiding traditional retail markups. The company operates showrooms in several states, including Washington, Massachusetts, Texas, and California, and also sells its products online. Additionally, Burrow has a manufacturing facility located in Mexico City, Mexico.

Expel

Series C in 2019
Expel, Inc. is a cybersecurity company that specializes in managed security software and services. Founded in 2016 and based in Herndon, Virginia, Expel offers a comprehensive security operations center (SOC)-as-a-service, which includes managed detection and response (MDR), threat hunting, remediation, and phishing support. The company’s platform, known as the Expel Workbench™, facilitates a collaborative experience, allowing customers to engage actively in their security operations. Users can monitor live investigations or receive detailed alerts throughout the investigative process. Expel’s approach emphasizes transparency and efficiency, enabling security teams to focus on strategic priorities while swiftly addressing threats such as ransomware, phishing, and supply chain attacks. With dedicated analysts available around the clock, Expel aims to enhance organizations' security posture by swiftly identifying and mitigating risks while reducing the noise of false positives.

WireWheel

Series A in 2018
WireWheel, Inc. is a software company specializing in data privacy management solutions, designed to assist organizations in complying with various data protection regulations such as the EU GDPR and HIPAA. Established in 2016 and headquartered in Arlington, Virginia, WireWheel offers a cloud-based platform that integrates machine learning and data science to streamline privacy program management and subject rights request handling. The platform facilitates the automatic mapping of public cloud assets and aids in managing third-party relationships, enabling organizations to effectively navigate compliance obligations while maximizing the value of their data assets. WireWheel's innovative approach positions its clients to operationalize privacy effectively within their enterprises.

StreamSets

Series C in 2018
StreamSets, Inc. is a developer of a cloud-based DataOps platform that facilitates modern data integration for enterprises, enabling the continuous flow of big, streaming, and traditional data into data science and analytics applications. Founded in 2014 and headquartered in San Francisco, California, the company offers solutions such as StreamSets Control Hub for designing and monitoring data pipelines, StreamSets Data Collector as an open-source execution engine for managing both streaming and batch data, and StreamSets Transformer for building data transformations across various sources. The platform supports diverse use cases, including integration for data lakes and warehouses, cloud data storage adoption, and the powering of real-time applications. StreamSets serves enterprise clients both in the United States and internationally, with additional offices in locations including Sunnyvale, Austin, London, Barcelona, Bengaluru, and Sydney.

Formlabs

Series D in 2018
Formlabs designs and manufactures professional 3D printing systems and materials for engineers, designers, educators, and manufacturers. The company offers high-resolution stereolithography printers such as Form 3, Form 3B, and Form 3L, along with post-processing equipment Form Wash and Form Cure, and the SLS-based Fuse 1 printer. It develops in-house high-performance resins and materials used across industries including education, dentistry, healthcare, jewelry, and manufacturing. Its software ecosystem includes PreForm, which prepares models for printing, and Form Cell for automated manufacturing. Formlabs serves customers worldwide and maintains headquarters in Somerville, Massachusetts with international offices. The company focuses on enabling designers and engineers to produce detailed, functional parts and complex geometries, expanding access to professional-grade 3D printing through scalable hardware, materials, and software solutions.

Automation Anywhere

Series A in 2018
Automation Anywhere, Inc. is a global leader in Robotic Process Automation (RPA), specializing in the development of AI-powered software solutions designed to enhance business efficiency. Founded in 2003 and headquartered in San Jose, California, the company offers a cloud-native platform that integrates RPA with artificial intelligence, machine learning, and analytics. Its flagship products include Automation Anywhere Enterprise, which automates IT and business processes; Automation Anywhere Server for streamlined business operations; and IQ Bot, a cognitive automation solution that addresses complex business tasks. Additionally, the company provides a comprehensive suite of testing tools, such as Testing Anywhere, which supports quality assurance across various platforms. Automation Anywhere also offers consulting services and collaborates strategically with Microsoft Azure. The company has expanded its presence internationally with offices in several major cities across the United States, Europe, the Middle East, and Asia.

Bestow

Series A in 2018
Bestow Inc., established in 2016 and based in Dallas, Texas, operates as a digital life insurance company. It provides life insurance services to individuals, leveraging data-driven technology applications and algorithmic underwriting to assess risks efficiently. The company partners with top carriers to enhance processes from origination to administration, aiming to increase financial stability for all.

Expel

Series B in 2018
Expel, Inc. is a cybersecurity company that specializes in managed security software and services. Founded in 2016 and based in Herndon, Virginia, Expel offers a comprehensive security operations center (SOC)-as-a-service, which includes managed detection and response (MDR), threat hunting, remediation, and phishing support. The company’s platform, known as the Expel Workbench™, facilitates a collaborative experience, allowing customers to engage actively in their security operations. Users can monitor live investigations or receive detailed alerts throughout the investigative process. Expel’s approach emphasizes transparency and efficiency, enabling security teams to focus on strategic priorities while swiftly addressing threats such as ransomware, phishing, and supply chain attacks. With dedicated analysts available around the clock, Expel aims to enhance organizations' security posture by swiftly identifying and mitigating risks while reducing the noise of false positives.

Burrow

Series A in 2018
Burrow, Inc. is a New York-based company that designs, manufactures, and supplies luxury furniture for residential use. Founded in 2016, Burrow specializes in creating easy-to-move and customizable seating options such as sofas, sectionals, loveseats, and armchairs, as well as tables, rugs, and various accessories. The furniture is crafted from sustainably-sourced hardwood and features non-toxic, scratch- and stain-resistant fabrics. Burrow aims to provide customers with comfortable and stylish furnishing alternatives while avoiding traditional retail markups. The company operates showrooms in several states, including Washington, Massachusetts, Texas, and California, and also sells its products online. Additionally, Burrow has a manufacturing facility located in Mexico City, Mexico.

Upskill

Corporate Round in 2018
Upskill designs and develops augmented reality software for industrial workforces. Its flagship platform, Skylight, enables companies to create smart glasses applications for various business scenarios, transforming operations using wearable devices. Serving industries such as manufacturing, healthcare, retail, and logistics, Upskill improves productivity, reduces errors, and enhances training.

Metavention

Series C in 2018
Metavention, Inc., founded in 2012 and based in Dover, Delaware, specializes in developing innovative treatments aimed at permanently disrupting the overactive nerves that contribute to high blood pressure and various metabolic diseases. The company has created a renal denervation procedure that employs radio frequency energy to target and modulate overactive sympathetic nerves. This trans-catheter device not only addresses issues related to high blood pressure but also focuses on conditions such as Type 2 diabetes by employing standard interventional vascular techniques. By providing physicians with advanced tools for diagnosis and treatment, Metavention aims to enhance patient outcomes for those suffering from metabolic disorders linked to sympathetic nervous system activity.

Personal Genome Diagnostics

Series B in 2018
Personal Genome Diagnostics, Inc. is a biotechnology company focused on patient-specific analyses of cancer genomes. Established in 2010 and headquartered in Baltimore, Maryland, the company has pioneered technologies for non-invasive "liquid biopsy" approaches, allowing for the detection of tumor-specific alterations in circulating cell-free DNA. Its offerings include the METDetect Assay for identifying MET gene amplifications, LungSelect for detecting actionable genetic alterations in non-small cell lung cancer patients, and PGDx elio plasma resolve, which analyzes various genetic mutations from plasma samples. Additionally, Personal Genome Diagnostics provides RNAcomplete, enabling researchers to extract both RNA and genomic DNA from a single tissue sample, and CancerXOME, which captures and analyzes coding regions of genes. The company collaborates with institutions like Mayo Clinic and partners with KingMed Diagnostics to enhance its research and diagnostic capabilities, thereby empowering oncologists and researchers with crucial genomic insights to combat cancer.

WireWheel

Seed Round in 2017
WireWheel, Inc. is a software company specializing in data privacy management solutions, designed to assist organizations in complying with various data protection regulations such as the EU GDPR and HIPAA. Established in 2016 and headquartered in Arlington, Virginia, WireWheel offers a cloud-based platform that integrates machine learning and data science to streamline privacy program management and subject rights request handling. The platform facilitates the automatic mapping of public cloud assets and aids in managing third-party relationships, enabling organizations to effectively navigate compliance obligations while maximizing the value of their data assets. WireWheel's innovative approach positions its clients to operationalize privacy effectively within their enterprises.

ThreatQuotient

Series C in 2017
Founded in 2013, ThreatQuotient develops a threat intelligence platform that centralizes management of external sources with internal security solutions. Its platform integrates with various tools for contextual intelligence and automates processes to improve efficiency and effectiveness of security operations.

Everactive

Venture Round in 2017
Everactive develops ultra-low-power chips for battery-less wireless sensors, enabling end-to-end IoT data services. Its solutions provide low-cost, long-lived, intelligent instrumentation for industrial operations across various applications.

Bestow

Seed Round in 2017
Bestow Inc., established in 2016 and based in Dallas, Texas, operates as a digital life insurance company. It provides life insurance services to individuals, leveraging data-driven technology applications and algorithmic underwriting to assess risks efficiently. The company partners with top carriers to enhance processes from origination to administration, aiming to increase financial stability for all.

VividCortex

Series A in 2017
VividCortex, Inc. is a developer of Software as a Service (SaaS) tools focused on database performance monitoring and analysis. Established in 2012 and headquartered in Washington, D.C., with additional offices in Arlington, Texas, and Charlottesville, Virginia, the company provides an innovative platform that enables organizations to measure, analyze, and optimize the performance of various open-source databases, including MySQL, PostgreSQL, Amazon Aurora, MongoDB, and Redis. VividCortex’s solution offers comprehensive visibility into database operations, allowing engineering teams to monitor performance across multiple servers simultaneously without the overhead typical of other monitoring tools. By utilizing patented algorithms and advanced statistical methods, the platform delivers actionable insights into database workload and query performance, helping clients proactively address issues and enhance application efficiency. The company serves a diverse clientele, including industry leaders like Etsy and GitHub, and is recognized for its unique, focused approach to database monitoring, which emphasizes clarity and depth in understanding database performance.

Juvo

Series B in 2017
Juvo Mobile Inc. is focused on creating financial identities for creditworthy individuals who are often excluded from traditional financial systems. Founded in 2014 and headquartered in San Francisco, with additional offices in São Paulo, Singapore, and Miami, Juvo collaborates with mobile network operators to leverage its proprietary Identity Scoring technology. This technology utilizes data science, machine learning, and game mechanics to develop identity-based relationships with prepaid users, thereby facilitating access to mobile financial services that were previously unattainable. By transforming subscriber consumption with real-time credit, Juvo aims to deepen connections between mobile operators and their subscribers, ultimately enhancing their ability to provide essential financial services. The company is privately held and supported by prominent figures in technology, mobile, and finance.

IonQ

Series A in 2017
IonQ is a quantum computing company that develops general-purpose quantum information processors based on trapped-ion technology. Its approach enables qubit replication, optical networkability, and optimized algorithms to support scalable quantum computation beyond classical capabilities. Founded in 2015 and based in College Park, Maryland, IonQ offers access to its quantum computers through cloud platforms, providing quantum-computing-as-a-service to a broad user base and select customers through its own cloud service. Revenue streams include QCaaS arrangements and related consulting and co-development contracts for algorithm design and system integration.

Illumitex

Venture Round in 2017
Illumitex Inc. is a manufacturer based in Austin, Texas, specializing in precision LEDs and LED lighting fixtures. Founded in 2005, the company offers a diverse range of lighting products tailored for horticultural, industrial, and architectural applications. Its horticultural lighting solutions include grow lights designed for large growers, vertical farms, greenhouses, and indoor gardening setups. Illumitex's innovative approach enhances traditional LED design, providing uniform and highly-precise light emissions. The company's products are utilized in various settings, including warehouses, commercial landscapes, and food processing facilities, and are distributed through stocking retailers across the United States. By integrating advanced optics technology, Illumitex aims to improve the brightness and efficiency of its lighting solutions for a variety of operational needs.

StreamSets

Series B in 2017
StreamSets, Inc. is a developer of a cloud-based DataOps platform that facilitates modern data integration for enterprises, enabling the continuous flow of big, streaming, and traditional data into data science and analytics applications. Founded in 2014 and headquartered in San Francisco, California, the company offers solutions such as StreamSets Control Hub for designing and monitoring data pipelines, StreamSets Data Collector as an open-source execution engine for managing both streaming and batch data, and StreamSets Transformer for building data transformations across various sources. The platform supports diverse use cases, including integration for data lakes and warehouses, cloud data storage adoption, and the powering of real-time applications. StreamSets serves enterprise clients both in the United States and internationally, with additional offices in locations including Sunnyvale, Austin, London, Barcelona, Bengaluru, and Sydney.

Senseonics

Post in 2017
Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems for individuals with diabetes. Founded in 1996, the company focuses on innovative and long-term implantable glucose monitoring solutions that utilize advanced fluorescence sensing technology. Its flagship products, Eversense and Eversense XL, are implantable CGM systems designed to monitor glucose levels for up to 90 and 180 days, respectively. These products aim to provide users with a reliable and stable means of glucose management, enhancing their ability to live confidently and manage their diabetes effectively. The majority of Senseonics' revenue comes from international markets, reflecting its strong presence in Europe.

Blispay

Venture Round in 2017
Blispay Inc. is a financial technology company based in Baltimore, Maryland, founded in 2014. It develops a mobile application designed for online bill payments and provides a unique financing solution for retailers through its Blispay Visa Card. This mobile-centric credit card allows merchants, regardless of size, to offer a streamlined in-store financing experience without the need for technical integration or financial commitments. Customers benefit from instant card issuance, six months of special financing options, and 2% cash back on purchases. Blispay aims to enhance the shopping experience by providing everyday credit and financing solutions that cater to the needs of both consumers and small to midsize retailers, ultimately helping businesses increase sales and improve customer satisfaction. The founding team comprises seasoned professionals with backgrounds at notable companies including PayPal and Microsoft.

Upskill

Series B in 2017
Upskill designs and develops augmented reality software for industrial workforces. Its flagship platform, Skylight, enables companies to create smart glasses applications for various business scenarios, transforming operations using wearable devices. Serving industries such as manufacturing, healthcare, retail, and logistics, Upskill improves productivity, reduces errors, and enhances training.

Expel

Series A in 2016
Expel, Inc. is a cybersecurity company that specializes in managed security software and services. Founded in 2016 and based in Herndon, Virginia, Expel offers a comprehensive security operations center (SOC)-as-a-service, which includes managed detection and response (MDR), threat hunting, remediation, and phishing support. The company’s platform, known as the Expel Workbench™, facilitates a collaborative experience, allowing customers to engage actively in their security operations. Users can monitor live investigations or receive detailed alerts throughout the investigative process. Expel’s approach emphasizes transparency and efficiency, enabling security teams to focus on strategic priorities while swiftly addressing threats such as ransomware, phishing, and supply chain attacks. With dedicated analysts available around the clock, Expel aims to enhance organizations' security posture by swiftly identifying and mitigating risks while reducing the noise of false positives.

ThreatQuotient

Series B in 2016
Founded in 2013, ThreatQuotient develops a threat intelligence platform that centralizes management of external sources with internal security solutions. Its platform integrates with various tools for contextual intelligence and automates processes to improve efficiency and effectiveness of security operations.

Vtesse

Series A in 2016
Vtesse, Inc. is a biopharmaceutical company based in Gaithersburg, Maryland, focused on developing treatments for patients with rare diseases. The company is primarily engaged in the clinical study of VTS-270 for the treatment of Niemann-Pick Disease Type C (NPC) and is also involved in the pre-clinical discovery and development of additional novel drugs for NPC and other lysosomal storage diseases. Vtesse operates as a subsidiary of Sucampo Pharmaceuticals, Inc. and is recognized as the first spin-out from Cydan Development, Inc., an orphan-drug accelerator. The company collaborates with the National Institutes of Health (NIH) to advance its clinical programs and is supported by a seasoned management team with extensive experience in drug development. Vtesse's initiatives aim not only to provide innovative therapies but also to offer resources and support for patients and families affected by NPC and related conditions.

VividCortex

Series A in 2016
VividCortex, Inc. is a developer of Software as a Service (SaaS) tools focused on database performance monitoring and analysis. Established in 2012 and headquartered in Washington, D.C., with additional offices in Arlington, Texas, and Charlottesville, Virginia, the company provides an innovative platform that enables organizations to measure, analyze, and optimize the performance of various open-source databases, including MySQL, PostgreSQL, Amazon Aurora, MongoDB, and Redis. VividCortex’s solution offers comprehensive visibility into database operations, allowing engineering teams to monitor performance across multiple servers simultaneously without the overhead typical of other monitoring tools. By utilizing patented algorithms and advanced statistical methods, the platform delivers actionable insights into database workload and query performance, helping clients proactively address issues and enhance application efficiency. The company serves a diverse clientele, including industry leaders like Etsy and GitHub, and is recognized for its unique, focused approach to database monitoring, which emphasizes clarity and depth in understanding database performance.

Blispay

Seed Round in 2016
Blispay Inc. is a financial technology company based in Baltimore, Maryland, founded in 2014. It develops a mobile application designed for online bill payments and provides a unique financing solution for retailers through its Blispay Visa Card. This mobile-centric credit card allows merchants, regardless of size, to offer a streamlined in-store financing experience without the need for technical integration or financial commitments. Customers benefit from instant card issuance, six months of special financing options, and 2% cash back on purchases. Blispay aims to enhance the shopping experience by providing everyday credit and financing solutions that cater to the needs of both consumers and small to midsize retailers, ultimately helping businesses increase sales and improve customer satisfaction. The founding team comprises seasoned professionals with backgrounds at notable companies including PayPal and Microsoft.

Zoomdata

Series C in 2016
Zoomdata, Inc. is a company focused on developing data visualization and analytics systems tailored for big data environments. Founded in 2012 and headquartered in Reston, Virginia, with an additional office in San Mateo, California, Zoomdata provides a visual analytics application that enables users to interact seamlessly with modern big data technologies, including Apache Hadoop and NoSQL data stores. Its offerings include Data Sharpening technology for real-time and historical data analysis, as well as Zoomdata Fusion, which allows the integration of various data sources without requiring data movement or transformation. The platform is designed to be mobile and touch-friendly, facilitating quick access to insights from billions of records. Users can create dashboards, fuse disparate data sources, and collaborate effectively, all while utilizing the company’s tools in both cloud and on-premises environments. Zoomdata also supports developers through its Developer Network, which provides resources such as guides and API documentation. The company operates as a subsidiary of Logi Analytics, Inc.

Everactive

Series B in 2015
Everactive develops ultra-low-power chips for battery-less wireless sensors, enabling end-to-end IoT data services. Its solutions provide low-cost, long-lived, intelligent instrumentation for industrial operations across various applications.

ZeroFOX

Series B in 2015
ZeroFOX is a cybersecurity company that provides external threat intelligence and protection against social media–based threats. It operates a cloud-based platform delivering real-time social threat analytics, protection, and monitoring to safeguard brands, people, and data across the public attack surface. Its solutions address phishing, credential compromise, impersonation, information leakage, brand hijacking, and physical or reputational risks to executives and high-profile individuals, with services including managed monitoring and protection. The company supports industries such as financial services, retail, government, healthcare, technology, education, media, and sports, and offers specialized protections for elections and high-value personnel.

ThreatQuotient

Series A in 2015
Founded in 2013, ThreatQuotient develops a threat intelligence platform that centralizes management of external sources with internal security solutions. Its platform integrates with various tools for contextual intelligence and automates processes to improve efficiency and effectiveness of security operations.

Upskill

Venture Round in 2015
Upskill designs and develops augmented reality software for industrial workforces. Its flagship platform, Skylight, enables companies to create smart glasses applications for various business scenarios, transforming operations using wearable devices. Serving industries such as manufacturing, healthcare, retail, and logistics, Upskill improves productivity, reduces errors, and enhances training.

Personal Genome Diagnostics

Series A in 2015
Personal Genome Diagnostics, Inc. is a biotechnology company focused on patient-specific analyses of cancer genomes. Established in 2010 and headquartered in Baltimore, Maryland, the company has pioneered technologies for non-invasive "liquid biopsy" approaches, allowing for the detection of tumor-specific alterations in circulating cell-free DNA. Its offerings include the METDetect Assay for identifying MET gene amplifications, LungSelect for detecting actionable genetic alterations in non-small cell lung cancer patients, and PGDx elio plasma resolve, which analyzes various genetic mutations from plasma samples. Additionally, Personal Genome Diagnostics provides RNAcomplete, enabling researchers to extract both RNA and genomic DNA from a single tissue sample, and CancerXOME, which captures and analyzes coding regions of genes. The company collaborates with institutions like Mayo Clinic and partners with KingMed Diagnostics to enhance its research and diagnostic capabilities, thereby empowering oncologists and researchers with crucial genomic insights to combat cancer.

StreamSets

Series A in 2015
StreamSets, Inc. is a developer of a cloud-based DataOps platform that facilitates modern data integration for enterprises, enabling the continuous flow of big, streaming, and traditional data into data science and analytics applications. Founded in 2014 and headquartered in San Francisco, California, the company offers solutions such as StreamSets Control Hub for designing and monitoring data pipelines, StreamSets Data Collector as an open-source execution engine for managing both streaming and batch data, and StreamSets Transformer for building data transformations across various sources. The platform supports diverse use cases, including integration for data lakes and warehouses, cloud data storage adoption, and the powering of real-time applications. StreamSets serves enterprise clients both in the United States and internationally, with additional offices in locations including Sunnyvale, Austin, London, Barcelona, Bengaluru, and Sydney.

Illumitex

Series C in 2015
Illumitex Inc. is a manufacturer based in Austin, Texas, specializing in precision LEDs and LED lighting fixtures. Founded in 2005, the company offers a diverse range of lighting products tailored for horticultural, industrial, and architectural applications. Its horticultural lighting solutions include grow lights designed for large growers, vertical farms, greenhouses, and indoor gardening setups. Illumitex's innovative approach enhances traditional LED design, providing uniform and highly-precise light emissions. The company's products are utilized in various settings, including warehouses, commercial landscapes, and food processing facilities, and are distributed through stocking retailers across the United States. By integrating advanced optics technology, Illumitex aims to improve the brightness and efficiency of its lighting solutions for a variety of operational needs.

ScienceLogic

Series D in 2015
ScienceLogic provides an AI-driven hybrid IT monitoring platform for service providers, enterprises, and government organizations worldwide. Its platform offers discovery, relationship mapping, monitoring, event management, automation, analytics, asset management, and ticketing across various technologies. With strategic alliances with major tech companies, ScienceLogic supports over 50,000 global clients in optimizing IT efficiency and ensuring business continuity.

Vtesse

Series A in 2015
Vtesse, Inc. is a biopharmaceutical company based in Gaithersburg, Maryland, focused on developing treatments for patients with rare diseases. The company is primarily engaged in the clinical study of VTS-270 for the treatment of Niemann-Pick Disease Type C (NPC) and is also involved in the pre-clinical discovery and development of additional novel drugs for NPC and other lysosomal storage diseases. Vtesse operates as a subsidiary of Sucampo Pharmaceuticals, Inc. and is recognized as the first spin-out from Cydan Development, Inc., an orphan-drug accelerator. The company collaborates with the National Institutes of Health (NIH) to advance its clinical programs and is supported by a seasoned management team with extensive experience in drug development. Vtesse's initiatives aim not only to provide innovative therapies but also to offer resources and support for patients and families affected by NPC and related conditions.

U.S. Renal Care

Private Equity Round in 2015
U.S. Renal Care operates a nationwide network of outpatient, home, and specialty dialysis centers delivering in-center and at-home hemodialysis and peritoneal dialysis services for end-stage renal disease. The company runs acute dialysis programs in partnership with local hospitals and supports families, caregivers, and physicians in ESRD care. Founded in 2000 and headquartered in Plano, Texas, it develops and operates dialysis centers through collaborations with local nephrologists, serving tens of thousands of patients across multiple states and select territories, including Guam and, according to some sources, Saudi Arabia.

Everactive

Series A in 2014
Everactive develops ultra-low-power chips for battery-less wireless sensors, enabling end-to-end IoT data services. Its solutions provide low-cost, long-lived, intelligent instrumentation for industrial operations across various applications.

Blueshift

Seed Round in 2014
Blueshift Labs, Inc. is a San Francisco-based company that provides an intelligent customer engagement platform designed to enhance brand interactions with consumers. Founded in 2013, the company offers an AI-first SmartHub CDP that consolidates customer data across various channels and applications, enabling brands to deliver relevant and personalized experiences in real-time. Blueshift's platform includes features such as email automation, mobile marketing, website personalization, contextual chat, and audience targeting, which allow marketers to tailor their communications based on customer interests, behaviors, and purchase patterns. The company serves notable clients including LendingTree, Udacity, Discovery, PayPal, Groupon, and the BBC, helping them to improve customer engagement and drive revenue growth. Blueshift also has offices in Charlotte, North Carolina; London, United Kingdom; and Pune, India.

Illumitex

Debt Financing in 2014
Illumitex Inc. is a manufacturer based in Austin, Texas, specializing in precision LEDs and LED lighting fixtures. Founded in 2005, the company offers a diverse range of lighting products tailored for horticultural, industrial, and architectural applications. Its horticultural lighting solutions include grow lights designed for large growers, vertical farms, greenhouses, and indoor gardening setups. Illumitex's innovative approach enhances traditional LED design, providing uniform and highly-precise light emissions. The company's products are utilized in various settings, including warehouses, commercial landscapes, and food processing facilities, and are distributed through stocking retailers across the United States. By integrating advanced optics technology, Illumitex aims to improve the brightness and efficiency of its lighting solutions for a variety of operational needs.

Zoomdata

Series B in 2014
Zoomdata, Inc. is a company focused on developing data visualization and analytics systems tailored for big data environments. Founded in 2012 and headquartered in Reston, Virginia, with an additional office in San Mateo, California, Zoomdata provides a visual analytics application that enables users to interact seamlessly with modern big data technologies, including Apache Hadoop and NoSQL data stores. Its offerings include Data Sharpening technology for real-time and historical data analysis, as well as Zoomdata Fusion, which allows the integration of various data sources without requiring data movement or transformation. The platform is designed to be mobile and touch-friendly, facilitating quick access to insights from billions of records. Users can create dashboards, fuse disparate data sources, and collaborate effectively, all while utilizing the company’s tools in both cloud and on-premises environments. Zoomdata also supports developers through its Developer Network, which provides resources such as guides and API documentation. The company operates as a subsidiary of Logi Analytics, Inc.

D2L

Series B in 2014
D2L is a global provider of cloud-based learning solutions for higher education, K-12, healthcare, government, and enterprise. It offers Brightspace, a scalable learning platform with integrated analytics and accessibility features, together with a suite of tools for adaptive learning, content management, assessment, ePortfolios, course catalogs, and campus engagement. The company serves hundreds of clients, including Fortune 1000 organizations, and supports more than eight million learners worldwide. Founded in 1999 and headquartered in Kitchener, Canada, D2L operates with offices and teams across North America, Europe, and Australia to deliver accessible, engaging, and personalized learning experiences.

NextNav

Series D in 2014
NextNav designs, develops, and deploys urban and indoor positioning technology solutions in the United States. Its positioning system allows mobile devices to determine their location in indoor and urban environments where GPS signals cannot be received, and provides location and height information with floor-level precision. The system is embedded into GPS chipsets, mobile phones, and other wireless devices. NextNav offers positioning services for E911, public safety, and emergency response, as well as consumer and commercial applications that require indoor location accuracy. It also provides Pinnacle, a Unity plug‑in that delivers precise altitude data to unlock 3D experiences for geolocation applications. Founded in 2007 and formerly known as Commlabs, the company is headquartered in Tyson's Corner, Virginia, with additional offices in Sunnyvale, California, and Bengaluru, India.

Cerecor

Series B in 2014
Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases. Founded in 2011 and headquartered in Rockville, Maryland, the company is advancing a clinical-stage pipeline that includes therapies for inherited metabolic disorders, such as CERC-801, CERC-802, and CERC-803, which are focused on congenital disorders of glycosylation. Additionally, Cerecor is developing CERC-006, an oral mTOR inhibitor aimed at treating complex lymphatic malformations, and two monoclonal antibodies: CERC-002, targeting the cytokine LIGHT for severe pediatric-onset Crohn's disease, and CERC-007, targeting IL-18 for autoimmune inflammatory diseases like adult onset Still's disease and multiple myeloma. Several of these therapies have received Orphan Drug Designation and Rare Pediatric Disease Designation, qualifying them for expedited review upon FDA approval. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions.

NexImmune

Venture Round in 2014
NexImmune, Inc. is a clinical-stage biopharmaceutical company based in Gaithersburg, Maryland, focused on developing innovative immuno-therapeutics utilizing its proprietary Artificial Immune (AIM) technology. Founded in 2011, the company aims to enhance the immune system's response to various diseases, including cancer, inflammation, viral infections, transplant rejection, and autoimmunity. NexImmune's lead product candidates are AIM101, an aAPC-based injectable therapy targeting specific solid tumors, and AIM ACT, an adoptive cellular therapy for hematological malignancies. The AIM technology facilitates a controllable and reproducible immune response by leveraging the body's T cells to initiate targeted actions against specific antigens, even in conditions where natural antigen presenting cells are compromised. Currently, NexImmune is advancing its therapies through clinical trials, including NEXI-001 for acute myeloid leukemia and NEXI-002 for multiple myeloma.

Senseonics

Venture Round in 2014
Senseonics Holdings, Inc. is a medical technology company based in Germantown, Maryland, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems for individuals with diabetes. Founded in 1996, the company focuses on innovative and long-term implantable glucose monitoring solutions that utilize advanced fluorescence sensing technology. Its flagship products, Eversense and Eversense XL, are implantable CGM systems designed to monitor glucose levels for up to 90 and 180 days, respectively. These products aim to provide users with a reliable and stable means of glucose management, enhancing their ability to live confidently and manage their diabetes effectively. The majority of Senseonics' revenue comes from international markets, reflecting its strong presence in Europe.

Upskill

Series A in 2014
Upskill designs and develops augmented reality software for industrial workforces. Its flagship platform, Skylight, enables companies to create smart glasses applications for various business scenarios, transforming operations using wearable devices. Serving industries such as manufacturing, healthcare, retail, and logistics, Upskill improves productivity, reduces errors, and enhances training.

ZeroFOX

Series A in 2014
ZeroFOX is a cybersecurity company that provides external threat intelligence and protection against social media–based threats. It operates a cloud-based platform delivering real-time social threat analytics, protection, and monitoring to safeguard brands, people, and data across the public attack surface. Its solutions address phishing, credential compromise, impersonation, information leakage, brand hijacking, and physical or reputational risks to executives and high-profile individuals, with services including managed monitoring and protection. The company supports industries such as financial services, retail, government, healthcare, technology, education, media, and sports, and offers specialized protections for elections and high-value personnel.

Kensho Technologies

Seed Round in 2014
Kensho Technologies, Inc. is a provider of advanced analytics, artificial intelligence, machine learning, and data visualization systems tailored for global banks and investment institutions. The company develops Kensho Financial Analytics Software, which delivers scalable analytical solutions to enhance decision-making within commercial entities. Kensho's offerings also include the Kensho Applied Mind, a sophisticated AI software that enables natural language processing to address complex financial inquiries in plain English. Additionally, Kensho operates a national security division known as Koto. Founded in 2012 and headquartered in Cambridge, Massachusetts, Kensho has expanded its presence with offices in New York, McLean, and Pacific Palisades. As of April 2018, Kensho Technologies operates as a subsidiary of S&P Global Inc.

Lumos Pharma

Series A in 2014
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company based in Austin, Texas, focused on developing and commercializing therapeutics for severe, rare, and genetic diseases. The company's lead product, LUM-201, is an oral small molecule currently undergoing Phase 2 clinical trials for pediatric growth hormone deficiency. In addition to its primary focus, Lumos has a licensing agreement with Ellipses Pharma Limited for the development and commercialization of nanoparticle formulations aimed at oncology indications. Founded in 2011, Lumos Pharma also has a commitment to addressing Creatine Transporter Deficiency, leveraging exclusive licenses for technologies developed at the University of Cincinnati and collaborating with key opinion leaders and the National Institutes of Health. The company engages in both clinical and preclinical research, exploring treatments that may enhance immune responses against cancer, and has partnerships for manufacturing its therapeutics.

Shareable Ink

Series C in 2013
Shareable Ink Corporation is a cloud computing company based in Nashville, Tennessee, that specializes in transforming point-of-care clinical documentation into structured data and analytics. Founded in 2009 and formerly known as Carescribe, Inc., the company offers a configurable and scalable iOS platform designed for a variety of healthcare settings including hospitals, surgery centers, and nursing homes. Its flagship product, Shareable Documents, utilizes Mimeo technology to automate the collection of clinical data at the point of care using Apple’s iPad. Additionally, Shareable Ink provides Shareable Integration, which integrates its mobile clinical documentation capabilities with clients' existing platforms, enhancing their mobile applications with clinical documentation functionality. As of May 2018, Shareable Ink operates as a subsidiary of Strategic Management Consulting, LLC.

ScienceLogic

Series C in 2013
ScienceLogic provides an AI-driven hybrid IT monitoring platform for service providers, enterprises, and government organizations worldwide. Its platform offers discovery, relationship mapping, monitoring, event management, automation, analytics, asset management, and ticketing across various technologies. With strategic alliances with major tech companies, ScienceLogic supports over 50,000 global clients in optimizing IT efficiency and ensuring business continuity.

Envisia Therapeutics

Series A in 2013
Envisia Therapeutics Inc. is a company focused on discovering and developing innovative therapies for ophthalmic medical needs. Founded in 2013 and based in Durham, North Carolina, the company utilizes its proprietary Particle Replication In Non-Wetting Templates (PRINT) technology to create a range of particle-based therapies. Envisia is particularly known for its lead product, ENV515, a prostaglandin analogue designed to deliver sustained intraocular pressure reduction for extended periods. In addition to this, the company is developing glaucoma drug therapies that leverage PRINT particle therapeutics to improve drug delivery and efficacy while addressing common barriers faced by existing ocular treatments. As the demand for more effective ocular therapeutics continues to grow, Envisia aims to enhance patient outcomes and convenience in the management of ocular diseases.

Zoomdata

Series A in 2013
Zoomdata, Inc. is a company focused on developing data visualization and analytics systems tailored for big data environments. Founded in 2012 and headquartered in Reston, Virginia, with an additional office in San Mateo, California, Zoomdata provides a visual analytics application that enables users to interact seamlessly with modern big data technologies, including Apache Hadoop and NoSQL data stores. Its offerings include Data Sharpening technology for real-time and historical data analysis, as well as Zoomdata Fusion, which allows the integration of various data sources without requiring data movement or transformation. The platform is designed to be mobile and touch-friendly, facilitating quick access to insights from billions of records. Users can create dashboards, fuse disparate data sources, and collaborate effectively, all while utilizing the company’s tools in both cloud and on-premises environments. Zoomdata also supports developers through its Developer Network, which provides resources such as guides and API documentation. The company operates as a subsidiary of Logi Analytics, Inc.

Scratch Music Group

Private Equity Round in 2013
Founded in 2002, Scratch Music Group operates DJ and music production learning centers worldwide, teaching over 500,000 people. It creates authentic events for global brands and offers professional wedding DJ services, having executed nearly 100,000 events across 25 countries.

Scratch Music Group

Venture Round in 2013
Founded in 2002, Scratch Music Group operates DJ and music production learning centers worldwide, teaching over 500,000 people. It creates authentic events for global brands and offers professional wedding DJ services, having executed nearly 100,000 events across 25 countries.

Intarcia Therapeutics

Series C in 2012
Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions requiring long-term treatment. The company is known for its innovative drug delivery platform, DUROS, which stabilizes and administers therapeutic proteins and peptides effectively. Among its key products is ITCA 650, currently in phase 3 clinical trials for type 2 diabetes, designed to provide patients with continuous dosing of an incretin mimetic therapy. Intarcia also explores treatments for obesity and other chronic disorders. Established in 1995 and headquartered in Boston, Massachusetts, Intarcia operates a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina. The company was previously known as BioMedicines, Inc. before adopting its current name in 2004.

Intarcia Therapeutics

Debt Financing in 2012
Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions requiring long-term treatment. The company is known for its innovative drug delivery platform, DUROS, which stabilizes and administers therapeutic proteins and peptides effectively. Among its key products is ITCA 650, currently in phase 3 clinical trials for type 2 diabetes, designed to provide patients with continuous dosing of an incretin mimetic therapy. Intarcia also explores treatments for obesity and other chronic disorders. Established in 1995 and headquartered in Boston, Massachusetts, Intarcia operates a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina. The company was previously known as BioMedicines, Inc. before adopting its current name in 2004.

Zoomdata

Seed Round in 2012
Zoomdata, Inc. is a company focused on developing data visualization and analytics systems tailored for big data environments. Founded in 2012 and headquartered in Reston, Virginia, with an additional office in San Mateo, California, Zoomdata provides a visual analytics application that enables users to interact seamlessly with modern big data technologies, including Apache Hadoop and NoSQL data stores. Its offerings include Data Sharpening technology for real-time and historical data analysis, as well as Zoomdata Fusion, which allows the integration of various data sources without requiring data movement or transformation. The platform is designed to be mobile and touch-friendly, facilitating quick access to insights from billions of records. Users can create dashboards, fuse disparate data sources, and collaborate effectively, all while utilizing the company’s tools in both cloud and on-premises environments. Zoomdata also supports developers through its Developer Network, which provides resources such as guides and API documentation. The company operates as a subsidiary of Logi Analytics, Inc.

Pentaho

Series C in 2012
Pentaho Corporation is a data integration and business analytics company that specializes in providing an open-source platform designed for big data deployments. Founded in 2004 and headquartered in Orlando, Florida, with an additional office in Tokyo, Japan, Pentaho offers a comprehensive suite of tools that enable organizations to analyze, visualize, and report on data from various sources. The platform includes capabilities for data extraction, preparation, and blending, as well as embedded analytics solutions that integrate seamlessly into applications and processes. Pentaho's services are utilized across multiple industries, including healthcare, retail, and financial services, and it supports organizations in harnessing the value of big data to enhance operational efficiency and drive actionable insights. The company is recognized for its leadership in open-source analytics projects and serves a diverse client base, including over 1,200 enterprise customers globally. Pentaho operates as a subsidiary of Hitachi Data Systems Corporation.

Bravo Health

Series A in 2012
Bravo Health, Inc. is a managed care organization that specializes in providing Medicare Advantage options, catering specifically to Medicare beneficiaries, including those who are dually eligible for Medicare and Medicaid. The company offers a range of plans, including special needs plans for individuals receiving institutional care or those with chronic health conditions, as well as private fee-for-service plans that allow members to choose their healthcare providers. Additionally, Bravo Health provides Part D prescription drug plans to cover medication needs. The company operates in multiple states, including Delaware, Maryland, Pennsylvania, Texas, and Washington, and has expanded its services to offer prescription drug coverage in 43 states. Founded in 1996 and headquartered in Baltimore, Maryland, Bravo Health was previously known as Elder Health, Inc.

D2L

Series A in 2012
D2L is a global provider of cloud-based learning solutions for higher education, K-12, healthcare, government, and enterprise. It offers Brightspace, a scalable learning platform with integrated analytics and accessibility features, together with a suite of tools for adaptive learning, content management, assessment, ePortfolios, course catalogs, and campus engagement. The company serves hundreds of clients, including Fortune 1000 organizations, and supports more than eight million learners worldwide. Founded in 1999 and headquartered in Kitchener, Canada, D2L operates with offices and teams across North America, Europe, and Australia to deliver accessible, engaging, and personalized learning experiences.

American Pathology Partners

Venture Round in 2012
American Pathology Partners, Inc. is a network of pathology laboratories based in Brentwood, Tennessee, that provides a comprehensive array of anatomic pathology and specialized testing services across the United States. Founded in 2008, the company focuses on various subspecialties, including women's health, surgical pathology, dermatopathology, gastrointestinal pathology, urologic pathology, hematopathology, and molecular testing. American Pathology Partners also offers technical and clinical support services such as immunohistochemistry, flow cytometry, and consultative services. Its laboratory facilities are located in Colorado, Florida, and North Carolina, serving a diverse clientele that includes physicians, hospitals, and surgery centers. The company is committed to delivering accurate diagnoses and rapid turnaround times, while also providing business support services designed to enhance operational efficiency for healthcare providers.

Sonatype

Series C in 2012
Sonatype, Inc. is a provider of software supply chain automation solutions, established in 2008 and headquartered in Fulton, Maryland, with additional offices in McLean, Virginia; London, United Kingdom; and Sydney, Australia. The company offers a comprehensive suite of tools designed to manage and secure software supply chains, including Nexus Lifecycle, Nexus Firewall, Nexus Auditor, Nexus Repository, and Nexus Repository OSS. These solutions help organizations control the flow of components, prevent risky elements from entering the supply chain, monitor applications in production, and efficiently store and distribute software components. Serving a diverse range of industries such as finance, government, technology, insurance, healthcare, and manufacturing, Sonatype supports approximately 70% of the Fortune 100 and is utilized by over 15 million developers globally. Recognized for its innovative workplace culture and growth, Sonatype continues to transform cloud-native development lifecycles, ensuring higher quality, maintainable, and secure software.

Eventup

Seed Round in 2012
Eventup is an online marketplace that connects event planners with a wide range of venues, including homes, lofts, hotels, galleries, warehouses, and other unique spaces. Founded in 2011 and headquartered in Santa Monica, California, the platform serves major U.S. cities such as Los Angeles, New York, San Francisco, Chicago, Miami, Boston, Atlanta, and Washington, D.C. Eventup streamlines the search, booking, and management of venues, offering property owners a way to monetize underused spaces while giving clients quick access to diverse event locations.

ScienceLogic

Series B in 2012
ScienceLogic provides an AI-driven hybrid IT monitoring platform for service providers, enterprises, and government organizations worldwide. Its platform offers discovery, relationship mapping, monitoring, event management, automation, analytics, asset management, and ticketing across various technologies. With strategic alliances with major tech companies, ScienceLogic supports over 50,000 global clients in optimizing IT efficiency and ensuring business continuity.

Illumitex

Venture Round in 2012
Illumitex Inc. is a manufacturer based in Austin, Texas, specializing in precision LEDs and LED lighting fixtures. Founded in 2005, the company offers a diverse range of lighting products tailored for horticultural, industrial, and architectural applications. Its horticultural lighting solutions include grow lights designed for large growers, vertical farms, greenhouses, and indoor gardening setups. Illumitex's innovative approach enhances traditional LED design, providing uniform and highly-precise light emissions. The company's products are utilized in various settings, including warehouses, commercial landscapes, and food processing facilities, and are distributed through stocking retailers across the United States. By integrating advanced optics technology, Illumitex aims to improve the brightness and efficiency of its lighting solutions for a variety of operational needs.

ISGN Corporation

Venture Round in 2011
ISGN Corporation is a prominent provider of mortgage technology and services for financial institutions, banks, credit unions, and lenders both domestically and internationally. The company offers a range of solutions including MORvision, a comprehensive mortgage lending system; ISGN Diamond and ISGN Catapult, loan origination systems; Gators, a settlement services and vendor management system; TCL Borrower Portal for construction loans; BridgeLink eCommerce Network for transaction delivery; LenStar for default management; FORTRACS for managing defaulted loan lifecycles; EZEscrow for escrow account management; LoanGPS for collaborative processing; and Valuation Advantage Desktop Appraisal. Additionally, ISGN provides contract processing services, mortgage processing services, loan quality audit and monitoring, title services, valuation services, and flood services. Founded in 2007, the company is headquartered in Melbourne, Florida, with additional locations across the United States and internationally. As of December 26, 2019, ISGN Corporation operates as a subsidiary of Sagent Auto, LLC.

Illumitex

Venture Round in 2011
Illumitex Inc. is a manufacturer based in Austin, Texas, specializing in precision LEDs and LED lighting fixtures. Founded in 2005, the company offers a diverse range of lighting products tailored for horticultural, industrial, and architectural applications. Its horticultural lighting solutions include grow lights designed for large growers, vertical farms, greenhouses, and indoor gardening setups. Illumitex's innovative approach enhances traditional LED design, providing uniform and highly-precise light emissions. The company's products are utilized in various settings, including warehouses, commercial landscapes, and food processing facilities, and are distributed through stocking retailers across the United States. By integrating advanced optics technology, Illumitex aims to improve the brightness and efficiency of its lighting solutions for a variety of operational needs.

AddThis

Series D in 2011
AddThis operates a social sharing and analytics platform that enables users to distribute and track digital content across various networks. It serves publishers, brands, consumers, and advertisers worldwide.

Millennial Media

Series D in 2011
Millennial Media Inc. is a prominent provider of mobile advertising solutions, catering to advertisers and developers in the United States and internationally. Founded in 2006 and headquartered in Baltimore, Maryland, the company offers a range of services that enable advertisers to effectively reach and engage their target audiences across various mobile devices. Its offerings include a demand-side platform for direct inventory access, a premium mobile advertising exchange, and tools for designing advertisements. Millennial Media also supports developers with software development kits for various ad formats, ad serving capabilities, and mediation tools that optimize ad requests from multiple sources. Additionally, the company operates MYDAS, a mobile advertising technology that identifies unique users and tailors ad delivery based on interests and behaviors. Millennial Media serves a significant portion of leading advertisers and is recognized for providing an attractive monetization platform for app developers and publishers.

Nektar Therapeutics

Post in 2011
Nektar Therapeutics is a biopharmaceutical company focused on developing novel drugs for cancer and autoimmune diseases. Its pipeline includes Bempegaldesleukin (NKTR-214), a CD122-preferential interleukin-2 pathway agonist designed to activate cancer-killing T cells and NK cells, currently in Phase I/II trials. The company also develops other immunotherapies such as NKTR-358 for autoimmune diseases and NKTR-262 for oncology, both in Phase I trials.

Opower

Series C in 2010
Opower, Inc. is a leading provider of cloud-based software solutions for the utility industry, headquartered in Arlington, Virginia. Founded in 2007, the company offers a range of services designed to enhance customer engagement and promote energy efficiency. Its software analyzes extensive energy data, delivering personalized insights to consumers and motivating them to reduce energy consumption. Opower’s offerings include home energy reports, smart meter-enabled communication, and a marketplace suite that facilitates product recommendations and digital rebate processing. Additionally, the company provides demand response solutions, such as peak day alerts, to inform customers about high-demand periods and encourage reduced usage. With a focus on customer satisfaction, Opower’s tools also include web applications and interfaces designed to streamline communication between utilities and consumers. Serving over 85 utility partners and more than 18 million consumers across multiple countries, Opower has significantly contributed to energy efficiency goals and enhanced customer participation in utility programs. As of June 2016, Opower operates as a subsidiary of Oracle Corporation.

Intarcia Therapeutics

Debt Financing in 2010
Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions requiring long-term treatment. The company is known for its innovative drug delivery platform, DUROS, which stabilizes and administers therapeutic proteins and peptides effectively. Among its key products is ITCA 650, currently in phase 3 clinical trials for type 2 diabetes, designed to provide patients with continuous dosing of an incretin mimetic therapy. Intarcia also explores treatments for obesity and other chronic disorders. Established in 1995 and headquartered in Boston, Massachusetts, Intarcia operates a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina. The company was previously known as BioMedicines, Inc. before adopting its current name in 2004.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.